# Yuflyma

NDC: 72606-024
Generic name: adalimumab-aaty
Labeler / Manufacturer: CELLTRION USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: KIT
Routes: —
Marketing started: 20230929

FDA application: BLA761219

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72606-024"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72606-024
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=526d626f-8c9f-496c-b838-00a73bb36383